- Prior Authorization: PA_APPLIES
- May be covered under Medical Benefit.
- NSCLC Systemic Therapy:
Duration: 1 year(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
Small Cell Lung Cancer:
Duration: 1 year(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
ECOG Score Requirement Included in Policy: N/A
Diagnosis Types: 3 of First line treatment;No previous therapy with a programmed death (PD-1/PD-L1)-directed therapy;Small Cell Lung Cancer
Concomitant Therapy Requirement: 1 of carboplatin and etoposide;cisplatin and etopside
|